Jieping Lei

Dr. Jieping Lei

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
QGQian Gao
Qian Gao
KZKaiyuan Zhen
Kaiyuan Zhen
LXLei Xia
Lei Xia
WWWei Wang
Wei Wang
YXYaping Xu
Yaping Xu
CWChen Wang
Chen Wang
Background: To explore the feasibility and effectiveness of multifaceted quality improvement intervention based on the clinical decision support system (CDSS) in VTE prophylaxis in hospitalized patients. Methods: A randomized, department-based clinical trial was conducted in the department of respiratory and critical care medicine, orthopedic, and general surgery wards. Patients aged ≥18 years, without VTE in admission, were allocated to the intervention group and received regular care combined with multifaceted quality improvement intervention based on CDSS during hospitalization. VTE prophylaxis rate and the occurrence of hospital-associated VTE events were analyzed as primary and secondary outcomes. Results: A total of 3644 eligible residents were enrolled in this trial. With the implementation of the multifaceted quality improvement intervention based on the CDSS, the VTE prophylaxis rate of the intervention group increased from 22.93% to 34.56% (p < 0.001), and the incidence of HA-VTE events increased from 0.49% to 1.00% (p = 0.366). In the nonintervention group, the VTE prophylaxis rate increased from 24.49% to 27.90% (p = 0.091), and the incidence of HA-VTE events increased from 0.47% to 2.02% (p = 0.001). Conclusions: Multifaceted quality improvement intervention based on the CDSS strategy is feasible and expected to facilitate implementation of the recommended VTE prophylaxis strategies and reduce the incidence of HA-VTE in hospital. However, it is necessary to conduct more multicenter clinical trials in the future to provide more reliable real-world evidence.

9 September 2023 in European Respiratory Journal
Verified
Conference Paper
Closed access
JLJieping Lei
Jieping Lei
KHKe Huang
Ke Huang
SWSinan Wu
Sinan Wu
TYTing Yang
Ting Yang
CWChen Wang
Chen Wang
Aims: To determine current prevalence and unique characteristics of individuals with chronic obstructive pulmonary disease (COPD) stage 0, early COPD, pre-COPD, and preserved ratio impaired spirometry (PRISm), young COPD, and mild COPD in general Chinese population. Methods: Data were obtained from the China Pulmonary Health study (2012-2015), a nationally representative cross-sectional investigation with 50,991 adults aged 20 years or older. Definitions of disease status were consistent with the latest 2023 GOLD criteria. Results: The age-adjusted prevalence of COPD stage 0, early COPD, pre-COPD, PRISm, young COPD, and mild COPD were 13.44%, 1.33%, 9.54%, 4.81%, 2.41%, and 4.04%, respectively. COPD stage 0 and pre-COPD presented with higher burdens of symptoms (i.e. cough, sputum, wheeze, and dyspnea), experienced more exacerbations, and harbored multiple comorbidities (e.g. rhinitis or allergic rhinitis, chronic bronchitis, cardiovascular disease, gastroesophageal reflux disease, depression, anxiety, anemia, periodontitis, etc.). Particularly, pre-COPD exhibited more small airway dysfunction. PRISm presented with lower post-bronchodilator FEV1%pred values. Young and mild COPD had lower pre- and post-bronchodilator FEV1/FVC ratios, and more reversibilities. Over the six subgroups of population, less than 12% ever took pulmonary function test; less than 1% reported a previously diagnosed COPD; less than 15% received pharmaceutical treatment and/or oxygen therapy. Conclusions: Prevalence and presentation are varied with different criteria of early stage of disease; more attention, better management. and further research should be paid on these individuals.

5 September 2026
Verified
Conference Paper
Closed access
JLJieping Lei
Jieping Lei
SWSinan Wu
Sinan Wu
JKJian Kang
Jian Kang
XZXiangyan Zhang
Xiangyan Zhang
LYLan Yang
Lan Yang
CWChen Wang
Chen Wang
Background: Patients with chronic obstructive pulmonary disease (COPD) often have psychological comorbidities such as anxiety and depression, leading to worse consequences. However, the prevalence and impact of the psychological disorders were underestimated. Methods: Data were obtained from the China Pulmonary Health Study, the largest epidemiological survey on chronic respiratory diseases in China. Pulmonary and extra-pulmonary symptoms were assessed using the COPD Assessment Test (CAT), and anxiety and depression were determined using the Hospital Anxiety and Depression Scale. Logistic regression and receiver operating characteristic curve analyses were applied. Results: Among 3,641 spirometry-defined COPD patients, the prevalence of anxiety and depression was 11.07% (10.05-12.09%) and 14.23% (13.09-15.36%), respectively. Female gender, rural residence, unemployment, lower family income, total CAT score and scores of pulmonary and extra-pulmonary symptom subscales of CAT were independently associated with increased prevalence of anxiety and/or depression in COPD patients. The optimal cut-off values of total CAT score were 9 (area under the curve: 0.637 [0.607-0.666]) and 7 (0.633 [0.607-0.659]) for anxiety and depression identification in all patients, respectively. Notably, the cut-off values were 7 (0.624 [0.582-0.665] and 0.616 [0.579-0.653] for anxiety and depression) for COPD patients in the rural area, whereas the values were 11 (0.652 [0.610-0.694] for anxiety) and 10 (0.654 [0.618-0.691] for depression) in the urban area. Conclusions: The findings highlighted the importance of early identification of anxiety and depression using CAT scales in COPD patients, especially in rural areas of China.